🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT03488966
Active, not recruiting Not applicable

Mindfulness Based Eating Awareness Training for Bariatric Surgery Patients

NCT03488966 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2017-03-20
Last updated
2026-06-11

Condition(s) studied

Obesity, MorbidEating Disorder Symptom

Investigational drug(s) / intervention(s)

Mindfulness Based Eating and Awareness Training

Mindfulness Based Eating and Awareness Training: Eight sessions of Mindfulness Based Eating and Awareness Training (MB-EAT) will be delivered once per week over the course of 8 weeks, following an introductory session. The treatment uses general mindfulness meditation and eating meditation to help participants bring greater awareness and understanding to their relationship with food. Homework consists of weekly mindfulness exercises.

Study summary

The purpose of this study is to evaluate the effects of Mindfulness Based Eating Awareness Training (MB-EAT) for patients who have had bariatric surgery on their weight and mental and physical health compared to patients who do not do this group. All participants will complete questionnaires evaluating eating and mental health before and after the group and 6 and 12 months later. They will have blood pressure readings at these times and complete a questionnaire about their digestive health. Our hypothesis is that participants will maintain their weight loss after bariatric surgery and have improvements in the other outcomes.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: 1. Post-bariatric surgery patients recruited from the Toronto Western Hospital-Bariatric Surgery Program (TWH-BSP) who are six months or more post-surgery, are experiencing self-reported difficulties adhering to post-surgery eating guidelines, and can commit to attending the group. 2. Fluent in English. 3. Have the capacity to provide informed consent. Exclusion Criteria: 1. Active suicidal ideation. 2. Active serious mental illness (i.e., psychotic disorder, bipolar disorder). 3. Active severe depression (i.e., current major depressive disorder diagnosis and PHQ-9 score \> 20 \[severe depression\]). 4. Active severe anxiety (i.e., current anxiety disorder diagnosis and GAD-7 score \> 15 \[severe anxiety\]). 5. Active symptoms of post-traumatic stress disorder (i.e., current diagnosis of post-traumatic stress disorder).

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Toronto General Hospital Toronto Ontario

More University Health Network, Toronto trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03488966 on ClinicalTrials.gov ↗ ← All trials in Canada